Edition:
United Kingdom

Molecular Templates Inc (MTEM.OQ)

MTEM.OQ on NASDAQ Stock Exchange Capital Market

7.04USD
15 Dec 2017
Change (% chg)

$-0.08 (-1.12%)
Prev Close
$7.12
Open
$7.17
Day's High
$7.20
Day's Low
$6.85
Volume
88,471
Avg. Vol
34,966
52-wk High
$11.88
52-wk Low
$3.90

Latest Key Developments (Source: Significant Developments)

Molecular Templates appoints Adam Cutler as CFO
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Molecular Templates Inc :Molecular Templates strengthens management team with appointment of Adam Cutler as Chief Financial Officer.Molecular Templates Inc - ‍announced appointment of Adam Cutler as Chief Financial Officer, effective Monday, November 13, 2017​.  Full Article

Molecular Templates Q3 loss per share $0.62
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Molecular Templates Inc ::Molecular Templates, Inc. Reports third quarter 2017 financial results.Q3 revenue $600,000.Q3 loss per share $0.62.Molecular Templates Inc - ‍MT-3724 advancing in clinical trials with new data expected in 1H18​.  Full Article

AbCheck and Molecular Templates collaborate to discover therapeutic oncology leads
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - Molecular Templates Inc ::Says Abcheck will use Absieve discovery platform to deliver antibodies against biological targets selected by Molecular Templates​.Says ‍further details were not disclosed​.  Full Article

Molecular Templates files for sale of 11.6 mln shares of common stock by selling stockholders‍​
Saturday, 16 Sep 2017 

Sept 15 (Reuters) - Molecular Templates Inc :Molecular Templates Inc - files for sale of 11.6 million shares of common stock by selling stockholders - sec filing‍​.  Full Article

Threshold Pharmaceuticals says to cut about a quarter of its workforce - SEC Filing
Thursday, 29 Sep 2016 

Threshold Pharmaceuticals Inc: Says implementing a workforce reduction constituting approximately a quarter of the company's workforce - SEC Filing . As a result of the workforce reduction, co estimates to record in Q4 a one-time severance-related charge about $0.9 million . Says notified employees affected by the workforce reduction on September 29, 2016 . Says expects to complete the workforce reduction by October 7, 2016 . Threshold pharmaceuticals inc says on September 29, Stewart Kroll, COO, notified that his position would be eliminated as part of workforce reduction .Undertaking workforce reduction to reduce expenses, preserve capital while focusing efforts on studies of Evofosfamide.  Full Article

Threshold Pharmaceuticals Q2 loss per share $0.10
Monday, 1 Aug 2016 

Threshold Pharmaceuticals Inc : Q2 revenue $110 million . Threshold Pharmaceuticals reports second quarter financial results . Qtrly loss per share $0.10 .Q2 earnings per share view $-0.10 -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-Molecular Templates appoints Adam Cutler as CFO

* Molecular Templates strengthens management team with appointment of Adam Cutler as Chief Financial Officer